Chronic Disease Management DTP Pharmacy and Insurance Direct Billing Platform

📌 Background

Driven by the advancement of prescription outflow policies and the steady growth in demand for long-term chronic disease medication, DTP pharmacies are able to handle the prescription routing of high-priced innovative drugs after commercial insurance direct billing eliminates the need for patients to pay out of pocket in advance. In 2026, JD Health, Ark Health, and others accelerated their layout of the AI chronic disease management closed loop: JD Health's total revenue in the first half of 2026 reached 40.9 billion RMB, a year-on-year increase of 15.9% (according to the company's interim performance announcement caliber), demonstrating that the 'in-store + at-home + payment' closed loop can already support a considerable scale.

👤 Target Customers

Patients with long-term prescriptions for chronic diseases such as hypertension and diabetes along with their family members, corporate supplementary medical insurance customers, and Huiminbao insurance participants

💰 Revenue Streams

1) Gross profit from pharmaceutical sales and delivery service fees; 2) Commercial insurance direct billing handling fees and claims data service fees; 3) Chronic disease management SaaS subscription and doctor service fees.

🧮 Cost Structure

Pharmacist labor costs, AI model training and operation costs, DTP innovative drug inventory capital occupancy, cold chain logistics costs

🛡️ Moat

Accumulation of patient medication data, direct-supply channels from innovative drug manufacturers, medical insurance claims direct-connection system, electronic prescription routing qualifications, and DTP medical insurance designated qualifications

🔑 Keys to Success

• AI chronic disease management model and prescription renewal automation accuracy rate
• Commercial insurance claims direct-connection system and designated DTP pharmacy network coverage
• Innovative drug manufacturer direct-supply channels and inventory turnover capacity

⚠️ Risks

• Inter-provincial execution differences in electronic prescription routing leading to obstructed cross-regional business
• Patient medication data leakage touching personal privacy compliance red lines

🏢 Cases

• Ark Health's AI chronic disease management and prescription routing platform achieved profitability in 2026 and gained recognition in top-tier journals
• JD Health's total revenue in the first half of the year reached 40.9 billion RMB, building an in-store plus at-home health service closed loop

📊 SWOT Analysis